March 21, 2022 12:52 PM EDT
Pharma
Manufacturing

Lon­za inks deal with first cus­tomer at re­cent­ly-ex­pand­ed Chi­na man­u­fac­tur­ing site

Josh Sullivan

Just one week af­ter Swiss drug­mak­er Lon­za an­nounced that an ex­pan­sion of its API de­vel­op­ment and man­u­fac­tur­ing labs at a Nan­sha, Chi­na, site has been …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times